Antiretroviral Therapy Not Continuous For At Least 6 Months Prior To Entry (Antiretroviral therapy not continuous for at least 6 months prior to entry)
CL Item
Change In Antiretroviral Therapy (Change in antiretroviral therapy)
CL Item
Cd4 Cell Count (CD4 cell count)
CL Item
Hiv-1 Rna (HIV-1 RNA)
CL Item
Plans To Start Antiretroviral Therapy Prior To Week 28 (Plans to start antiretroviral therapy prior to Week 28)
CL Item
Hematologic Parameters Not Met (Hematologic parameters not met)
CL Item
Laboratory Parameters Not Met (Laboratory parameters not met)
CL Item
Current Or History Of Anal Or Perianal Carcinoma (Current or history of anal or perianal carcinoma)
CL Item
Use Of Any Systemic Antineoplastic Or Immunomodulatory Treatment, Systemic Corticosteroids, Investigational Vaccines, Interleukins, Interferons, Growth Factors, Or Ivig Within 45 Days Prior To Study Entry (Use of any systemic antineoplastic or immunomodulatory treatment, systemic corticosteroids, investigational vaccines, interleukins, interferons, growth factors, or IVIG within 45 days prior to study entry)
CL Item
Active Drug Or Alcohol Use Or Dependence That, In The Opinion Of The Site Investigator, Would Interfere With Adherence To Study Requirements (Active drug or alcohol use or dependence that, in the opinion of the site Investigator, would interfere with adherence to study requirements)
CL Item
Serious Illness Requiring Systemic Treatment And/or Hospitalization Within 45 Days Prior To Entry (Serious illness requiring systemic treatment and/or hospitalization within 45 days prior to entry)
CL Item
Participant Is Currently Receiving Anticoagulation Therapy Other Than Acetylsalicylic Acid (Participant is currently receiving anticoagulation therapy other than acetylsalicylic acid)
The Maximum Number Of Participants With Hpv Type 16 Are Already Enrolled (The maximum number of participants with HPV type 16 are already enrolled)
CL Item
The Maximum Number Of Participants With Hpv Type 18 Are Already Enrolled (The maximum number of participants with HPV type 18 are already enrolled)
CL Item
The Maximum Number Of Participants On Antiretroviral Therapy Are Already Enrolled (The maximum number of participants on antiretroviral therapy are already enrolled)
CL Item
Other (Other)
C17649 (NCI Thesaurus) C0205394 (UMLS 2011AA)
CL Item
Positive For Both Hpv Type 16 And Hpv Type 18 (Positive for both HPV type 16 and HPV type 18)
CL Item
Anal Cytology With Hsil, Asc-h, Or Suggestive Of Carcinoma (Anal cytology with HSIL, ASC-H, or suggestive of carcinoma)